Abstract：Objective To evaluate the outcomes and toxicities of elderly nasopharyngeal carcinoma (NPC) treated with conventional radiotherapy alone. Methods From January 1995 to December 1998, 95 newly diagnosed nasopharyngeal carcinoma with age≥65 years treated in our hospital. The clinical data were analyzed retrospectively. Kaplan-Meier method was used for analysis of local-regional control survival and distant metastasis-free survival. The Logrank test was used for univariate prognostic analysis and Cox regression was used for multivariable prognostic analysis. Results The follow-up rate was 98%. The 3-, 5- and 8-year local-regional control (LRC) and distant metastasis-free survival (DMFS) rates were 89%, 87%, 84% and 85%, 79%, 79%, respectively. The most common acute toxicities were grade1-2 leukopenia (36%), skin reaction (64%) and mucositis (66%). The most frequent late toxicities were hearing impairment (8%), trismus (10%) and radiation-induced cranial neuropathy (5%). In univariate analysis, interruption of radiotherapy (χ2=7.45,P=0.006) and regional neck lymph nodes response (χ2=4.17,P=0.041) was the prognostic factors for LRC, T stage (χ2=4.16,P=0.032), N stage (χ2=4.66,P=0.031) and interruption of radiotherapy (χ2=9.42,P=0.002) was the prognostic factors for DMFS. In multivariable analysis, interruption of radiotherapy and the regional neck lymph nodes response were the prognostic factors for LRC (χ2=6.19,P=0.013 and χ2=12.16,P=0.002;respectively), N stage and radiotherapy interruption were prognostic factors for DMFS.(χ2=15.06, P=0.000 and χ2=21.62,P=0.000;respectively). Conclusions Conventional radiotherapy alone for elder NPC can produce satisfactory results with acceptable treatment-relative toxicities. Our experience showed that the early N stage, without radiotherapy interruption and good regional lymph nodes response had a good long-term prognosis.
JIANG Wei-ping,WU Jun-xin,CHEN Chuan-ben et al. Long-term results of elderly nasopharyngeal carcinoma treated with conventional radiotherapy alone in 95 cases[J]. Chinese Journal of Radiation Oncology, 2012, 21(1): 7-10.
[1] Xian WW, Han F, Lu TX, et al. Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys,2009,74:1070-1076. [2] Ho HC, Su YC, Lee MS, et al. A preliminary result of concurrent chemoradiation with weekly cisplatin in elderly nasopharyngeal carcinoma patients. Acta Otolaryngol,2008,128:930-935. [3] Xiao WW, Huang SM, Han F, et al. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy:long-term results of a phase 2 study. Cancer,2011,107:1874-1883. [4] 潘建基,张瑜,林少俊,等.1706例鼻咽癌放疗远期疗效分析. 中华放射肿瘤学杂志,2008,17:247-251. [5] 高剑铭,曾益新,崔念基.等.915例单纯根治性放疗鼻咽癌分期系统比较及建议(一)—对′92福州分期的校验.癌症,2005,24:1165-1172. [6] Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy:the Hong Kong experience. Int J Radiat Oncol Biol Phys,2004,60:1440-1450. [7] 卢泰祥,赵充,吴少雄,等.鼻咽癌单纯常规外照射放疗疗效的分析.中华肿瘤杂志,2010,27:620-622. [8] 易俊林,高黎,徐国镇,等.147例鼻咽癌调强放疗结果分析. 中华放射肿瘤学杂志,2008,17:329-334. [9] Huang HH, O′Sullivan B, Waldron J, et al. Patterns of care in elderly head-and-neck cancer radiation oncology patients:a single-center cohort study. Int J Radiat Oncol Biol Phys,2011,79:46-51. [10] Bhattacharyya N. A matched survival analysis for squamous cell carcinoma of the head and neck in the elderly. Laryngoscope,2003,113:368-372. [11] Metges JP, Eschwege F, de Crevoisier R, et al. Radiotherapy in head and neck cancer in the elderly:a challenge. Crit Rev Oncol Hematol,2000,34:195-203. [12] 亓姝楠,谢方云,卢泰祥,等.老年鼻咽癌患者的临床特征. 癌症,2006,25:740-743. [13] Lee AW, Lau WH, Tung SY, et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally advanced nasopharyngeal carcinoma:NPC-9901 Trial by the Hong Kong nasopharyngeal cancer study group. J Clin Oncol,2005,23:6966-6975. [14] Chan AT, Teo PM, Ngan RK, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma:progression-free survival analysis of a phase Ⅲ randomized trial. J Clin Oncol,2002,20:2038-2044. [15] Zheng J, Wang G, Yang GY,et al. Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Jpn J Clin Oncol, 2010,40:425-431. [16] 孔琳,张有望,吴永如,等.鼻咽癌放射治疗后颅神经损伤影响因素研究. 中华放射肿瘤学杂志,2005,14:10-14. [17] Italiano A, Ortholan C, Dassonville O, et al. Head and neck squamous cell carcinoma in patients aged> or= 80 years:Patterns of care and survival. Cancer,2008,113:3160-3168. [18] Bernardi D, Barzan L, Franchin G, et al. Treatment of head and neck cancer in elderly patients:state of the art and guidelines. Crit Rev Oncol Hematol,2005,53:71-80. [19] Chau RM, Teo PM, Kam MK, et al. Dosimetric comparison between dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma:to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Med Dosim,2007,32:263-270. [20] Guerrero-Urbano MT, Clark CH, Kong C, et al. Target volume definition for head and neck intensity modulated radiotherapy:pre-clinical evaluation of PARSPORT trial guidelines. Clin Oncol,2007,19:604-613. [21] Taheri-Kadkhoda Z, Bjrk-Eriksson T, Nill S, et al. Intensity-modulated radiotherapy of nasopharyngeal carcinoma:a comparative treatment planning study of photons and protons. Radiat Oncol,2008,3:4. [22] Fang FM, Tsai WL, then HC, et al. Intensity-modulated or conformal radiotherapy improve the quality of lire of patients with nasopharyngeal carcinoma. Cancer,2007,109:313-321. [23] Li JJ, Guo YK, Tang QL, et al. Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma. J Laryngol Otol,2010,124:32-36. [24] 陈春燕,韩非,赵充,等.34例鼻咽癌单纯放疗远期疗效分析. 中华放射肿瘤学杂志,2008,17:411-415.
2012, Vol. 21 
